Salim Yazji

Dr. Yazji brings to Oncternal over 20 years of experience in the biotech and pharmaceutical industries, including successful registrations. Most recently, he was the co-founder and CEO of Ajuta Therapeutics, Inc. and the founder of Elpida Therapeutics. Dr. Yazji held multiple seats as a board member and scientific advisory board member at several biotech companies. Past leadership roles include Chief Medical Officer at PMV Pharma, Inc. and Executive Vice President and Chief Medical Officer at Calimmune, Inc., Vice president and Global Therapeutics Head at Baxalta, Inc., and Vice President and Therapeutic Area Head of Oncology at Baxter. Dr. Yazji has also held multiple leadership positions at Novartis Pharmaceutical, Exelixis, Inc., PDL BioPharma, Inc., and Johnson & Johnson. Dr. Yazji obtained his medical degree from the Pavlov School of Medicine, University of St. Petersburg, St. Petersburg, Russia, and completed his postgraduate training at the University of Texas M.D. Anderson Cancer Center, Park Plaza Hospital, Houston and Almozov Hospital, St. Petersburg, Russia.